![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TRIM16 |
Gene summary for TRIM16 |
![]() |
Gene information | Species | Human | Gene symbol | TRIM16 | Gene ID | 10626 |
Gene name | tripartite motif containing 16 | |
Gene Alias | EBBP | |
Cytomap | 17p12 | |
Gene Type | protein-coding | GO ID | GO:0001816 | UniProtAcc | O95361 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
10626 | TRIM16 | LZE2T | Human | Esophagus | ESCC | 3.25e-04 | 6.72e-01 | 0.082 |
10626 | TRIM16 | LZE4T | Human | Esophagus | ESCC | 1.88e-39 | 1.47e+00 | 0.0811 |
10626 | TRIM16 | LZE5T | Human | Esophagus | ESCC | 7.14e-06 | 7.32e-01 | 0.0514 |
10626 | TRIM16 | LZE7T | Human | Esophagus | ESCC | 5.67e-16 | 9.03e-01 | 0.0667 |
10626 | TRIM16 | LZE8T | Human | Esophagus | ESCC | 1.36e-11 | 3.87e-01 | 0.067 |
10626 | TRIM16 | LZE20T | Human | Esophagus | ESCC | 1.22e-04 | 3.25e-01 | 0.0662 |
10626 | TRIM16 | LZE21D1 | Human | Esophagus | HGIN | 2.08e-02 | 1.63e-01 | 0.0632 |
10626 | TRIM16 | LZE22D1 | Human | Esophagus | HGIN | 1.21e-03 | 2.26e-01 | 0.0595 |
10626 | TRIM16 | LZE22T | Human | Esophagus | ESCC | 5.64e-12 | 1.02e+00 | 0.068 |
10626 | TRIM16 | LZE24T | Human | Esophagus | ESCC | 4.60e-20 | 7.04e-01 | 0.0596 |
10626 | TRIM16 | LZE21T | Human | Esophagus | ESCC | 6.36e-17 | 1.12e+00 | 0.0655 |
10626 | TRIM16 | LZE6T | Human | Esophagus | ESCC | 9.98e-03 | 1.39e-01 | 0.0845 |
10626 | TRIM16 | P1T-E | Human | Esophagus | ESCC | 9.51e-22 | 8.33e-01 | 0.0875 |
10626 | TRIM16 | P2T-E | Human | Esophagus | ESCC | 9.40e-16 | 3.38e-01 | 0.1177 |
10626 | TRIM16 | P4T-E | Human | Esophagus | ESCC | 1.36e-67 | 1.72e+00 | 0.1323 |
10626 | TRIM16 | P5T-E | Human | Esophagus | ESCC | 3.82e-33 | 7.06e-01 | 0.1327 |
10626 | TRIM16 | P8T-E | Human | Esophagus | ESCC | 5.54e-20 | 4.70e-01 | 0.0889 |
10626 | TRIM16 | P9T-E | Human | Esophagus | ESCC | 5.71e-41 | 9.04e-01 | 0.1131 |
10626 | TRIM16 | P10T-E | Human | Esophagus | ESCC | 9.32e-10 | 2.70e-01 | 0.116 |
10626 | TRIM16 | P11T-E | Human | Esophagus | ESCC | 6.55e-12 | 8.91e-01 | 0.1426 |
Page: 1 2 3 4 5 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00439674 | Oral cavity | OSCC | histone H4 acetylation | 49/7305 | 67/18723 | 1.45e-08 | 2.91e-07 | 49 |
GO:00435887 | Oral cavity | OSCC | skin development | 143/7305 | 263/18723 | 2.77e-07 | 4.27e-06 | 143 |
GO:00085449 | Oral cavity | OSCC | epidermis development | 171/7305 | 324/18723 | 2.89e-07 | 4.43e-06 | 171 |
GO:004343419 | Oral cavity | OSCC | response to peptide hormone | 208/7305 | 414/18723 | 1.83e-06 | 2.35e-05 | 208 |
GO:00302166 | Oral cavity | OSCC | keratinocyte differentiation | 81/7305 | 139/18723 | 3.16e-06 | 3.81e-05 | 81 |
GO:00099139 | Oral cavity | OSCC | epidermal cell differentiation | 109/7305 | 202/18723 | 1.08e-05 | 1.14e-04 | 109 |
GO:00456825 | Oral cavity | OSCC | regulation of epidermis development | 41/7305 | 65/18723 | 7.29e-05 | 5.73e-04 | 41 |
GO:00456045 | Oral cavity | OSCC | regulation of epidermal cell differentiation | 36/7305 | 58/18723 | 3.15e-04 | 1.96e-03 | 36 |
GO:00483853 | Oral cavity | OSCC | regulation of retinoic acid receptor signaling pathway | 13/7305 | 16/18723 | 7.05e-04 | 3.89e-03 | 13 |
GO:00483843 | Oral cavity | OSCC | retinoic acid receptor signaling pathway | 21/7305 | 31/18723 | 1.13e-03 | 5.75e-03 | 21 |
GO:00439661 | Oral cavity | OSCC | histone H3 acetylation | 36/7305 | 61/18723 | 1.21e-03 | 6.10e-03 | 36 |
GO:000181910 | Oral cavity | OSCC | positive regulation of cytokine production | 213/7305 | 467/18723 | 1.93e-03 | 8.96e-03 | 213 |
GO:00456166 | Oral cavity | OSCC | regulation of keratinocyte differentiation | 23/7305 | 37/18723 | 3.66e-03 | 1.51e-02 | 23 |
GO:0045684 | Oral cavity | OSCC | positive regulation of epidermis development | 20/7305 | 32/18723 | 6.05e-03 | 2.28e-02 | 20 |
GO:0045618 | Oral cavity | OSCC | positive regulation of keratinocyte differentiation | 13/7305 | 19/18723 | 9.07e-03 | 3.26e-02 | 13 |
GO:0045606 | Oral cavity | OSCC | positive regulation of epidermal cell differentiation | 17/7305 | 27/18723 | 1.01e-02 | 3.49e-02 | 17 |
GO:0032526 | Oral cavity | OSCC | response to retinoic acid | 54/7305 | 107/18723 | 1.04e-02 | 3.54e-02 | 54 |
GO:001820513 | Oral cavity | LP | peptidyl-lysine modification | 136/4623 | 376/18723 | 3.64e-07 | 1.06e-05 | 136 |
GO:004354312 | Oral cavity | LP | protein acylation | 93/4623 | 243/18723 | 1.65e-06 | 3.86e-05 | 93 |
GO:001839412 | Oral cavity | LP | peptidyl-lysine acetylation | 68/4623 | 169/18723 | 5.60e-06 | 1.11e-04 | 68 |
Page: 1 2 3 4 5 6 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TRIM16 | SNV | Missense_Mutation | novel | c.1115N>T | p.Ala372Val | p.A372V | O95361 | protein_coding | tolerated(0.13) | benign(0.044) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
TRIM16 | SNV | Missense_Mutation | novel | c.1639N>C | p.Asp547His | p.D547H | O95361 | protein_coding | deleterious(0.03) | probably_damaging(0.956) | TCGA-C5-A7X5-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Chemotherapy | carboplatin | PD |
TRIM16 | SNV | Missense_Mutation | c.1081G>C | p.Glu361Gln | p.E361Q | O95361 | protein_coding | tolerated(0.07) | possibly_damaging(0.796) | TCGA-EK-A2R9-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD | |
TRIM16 | SNV | Missense_Mutation | novel | c.251C>G | p.Thr84Ser | p.T84S | O95361 | protein_coding | tolerated(0.65) | benign(0.014) | TCGA-JW-A5VL-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
TRIM16 | SNV | Missense_Mutation | rs746816242 | c.946N>A | p.Glu316Lys | p.E316K | O95361 | protein_coding | deleterious(0.02) | benign(0.02) | TCGA-UC-A7PF-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
TRIM16 | SNV | Missense_Mutation | c.1646N>T | p.Gly549Val | p.G549V | O95361 | protein_coding | deleterious(0.01) | probably_damaging(0.933) | TCGA-AA-3864-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD | |
TRIM16 | SNV | Missense_Mutation | c.449N>A | p.Cys150Tyr | p.C150Y | O95361 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-AA-A02R-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
TRIM16 | SNV | Missense_Mutation | c.907C>A | p.Leu303Met | p.L303M | O95361 | protein_coding | deleterious(0.04) | probably_damaging(0.968) | TCGA-AM-5821-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
TRIM16 | SNV | Missense_Mutation | novel | c.29N>A | p.Gly10Glu | p.G10E | O95361 | protein_coding | deleterious_low_confidence(0.04) | benign(0.011) | TCGA-AZ-6598-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
TRIM16 | SNV | Missense_Mutation | c.121G>A | p.Glu41Lys | p.E41K | O95361 | protein_coding | tolerated(0.15) | benign(0.006) | TCGA-CK-5912-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |